新华三:2024年Context技术白皮书

Context 技术白皮书 Copyright © 2024 新华三技术有限公司 版权所有,保留一切权利。 非经本公司书面许可,任何单位和个人不得擅自摘抄、复制本文档内容的部分或全部,并不得以任何形式传播。 除新华三技术有限公司的商标外,本手册中出现的其它公司的商标、产品标识及商品名称,由各自权利人拥有。 本文中的内容为通用性技术信息,某些信息可能不适用于您所购买的产品。 i 目 录 1 概述 ·························································································································································· 1 1.1 产生背景 ··············································································································································· 1 1.2 技术优点 ··············································································································································· 1 2 Context 技术实现 ····································································································································· 2 2.1 Context 的创建 ····································································································································· 2 2.2 Context 资源分配 ·································································································································· 2 2.2.1 将 Context 进驻安全引擎 ··········································································································· 2 2.2.2 为 Context 分配软硬件资源········································································································ 3 2.3 限制 Context 使用的资源 ······················································································································ 4 2.4 Context 的启动 ····································································································································· 6 2.4.1 Context-OS ································································································································ 6 2.4.2 Context 的数据同步 ··················································································································· 7 2.4.3 Context 的进程隔离 ··················································································································· 7 2.5 Context 访问和管理 ······························································································································ 7 2.5.1 登录通道 ···································································································································· 7 2.5.2 配置方式 ···································································································································· 8 2.5.3 配置文件 ···································································································································· 8 2.5.4 日志输出 ···································································································································· 8 2.5.5 用户管理 ··································································································································

立即下载
综合
2024-12-30
17页
0.6M
收藏
分享

新华三:2024年Context技术白皮书,点击即可下载。报告格式为PDF,大小0.6M,页数17页,欢迎下载。

本报告共17页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共17页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
其他模态管线
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
ADC 管线
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
已批准多发性骨髓瘤药物失去独占权的时间
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
部分双抗和三抗 T 细胞衔接器
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
GPRC5D 和 FcRH5 双抗比较
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
潜在抗原靶点
综合
2024-12-30
来源:骨髓瘤展望:2024年革新疗法或推动2030年全球骨髓瘤药物市场规模增至330亿美元
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起